Cargando…
Proteomic Advances in Glial Tumors through Mass Spectrometry Approaches
Being the fourth leading cause of cancer-related death, glial tumors are highly diverse tumor entities characterized by important heterogeneity regarding tumor malignancy and prognosis. However, despite the identification of important alterations in the genome of the glial tumors, there remains a ga...
Autores principales: | Pirlog, Radu, Susman, Sergiu, Iuga, Cristina Adela, Florian, Stefan Ioan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6722920/ https://www.ncbi.nlm.nih.gov/pubmed/31357616 http://dx.doi.org/10.3390/medicina55080412 |
Ejemplares similares
-
The role of p-Stat3 Y705 immunohistochemistry in glioblastoma prognosis
por: Susman, Sergiu, et al.
Publicado: (2019) -
Mass Spectrometry-Based Omics for the Characterization of Triple-Negative Breast Cancer Bio-Signature
por: Pralea, Ioana-Ecaterina, et al.
Publicado: (2020) -
The role of the pathology department in the preanalytical phase of molecular analyses
por: Susman, Sergiu, et al.
Publicado: (2018) -
Involvement of Microglia in the Pathophysiology of Intracranial Aneurysms and Vascular Malformations—A Short Overview
por: Timis, Teodora Larisa, et al.
Publicado: (2021) -
The Roles of miRNA in Glioblastoma Tumor Cell Communication: Diplomatic and Aggressive Negotiations
por: Buruiană, Andrei, et al.
Publicado: (2020)